![Peter Ratcliffe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Ratcliffe
Directeur/Membre du Conseil chez
IMMUNOCORE HOLDINGS PLC
Fortune : 9 620 $ au 31/05/2026
Profil
Mr. Peter J.
Ratcliffe is an Independent Non-Executive Director at Immunocore Holdings Plc, a Director-Clinical Research at The Francis Crick Institute Ltd., a Director-Target Discovery Institute at University of Oxford, a Member at American Academy of Arts & Sciences and a Member at European Molecular Biology Organization.
He is on the Board of Directors at Immunocore Holdings Plc, ReOx Ltd., Target Discovery Institute and Immunocore Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/05/2026 | 333 ( 0 % ) | 9 620 $ | 31/05/2026 |
Postes actifs de Peter Ratcliffe
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Directeur/Membre du Conseil | 01/11/2020 |
ReOx Ltd.
 ReOx Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Fondateur | 01/06/2003 |
The Francis Crick Institute Ltd.
 The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Corporate Officer/Principal | - |
European Molecular Biology Organization | Corporate Officer/Principal | - |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Corporate Officer/Principal | - |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Directeur/Membre du Conseil | - |
Target Discovery Institute | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ReOx Ltd.
ReOx Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services Operates as organization which honours excellence and convenes leaders | Commercial Services |
European Molecular Biology Organization | |
The Francis Crick Institute Ltd.
The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Miscellaneous |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
Target Discovery Institute | |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes transformative medicines for cancer, infection and autoimmune disease | Health Technology |
